Cadrenal Therapeutics Inc (CVKD)

Finanzdaten der Cadrenal Therapeutics Inc-Aktie (CVKD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	32.85%3.34	2.51	3.07	2.73	3.73
Research and Development	8.60%0.71	0.77	0.67	0.69	1.08
Operating Income/Loss	32.85%-3.34	-2.51	-3.07	-2.73	-3.73
Nonoperating Income/Loss	0.02%0.02	0.02	0.03	0.05	0.07
	33.09%-3.32	-2.50	-3.04	-2.69	-3.67
Attributable To Parent	33.09%-3.32	-2.50	-3.04	-2.69	-3.67
Available To Common Stockholders, Basic	33.09%-3.32	-2.50	-3.04	-2.69	-3.67
Basic Average Shares	21.00%2.91	2.41	-	2.04	1.96
Diluted Average Shares	21.00%2.91	2.41	-	2.04	1.96
Basic Earnings Per Share	9.62%-1.14	-1.04	-	-1.31	-1.87
Diluted Earnings Per Share	9.62%-1.14	-1.04	-	-1.31	-1.87